Recent Company News

• 07:46 PM ET Feb 11, 2026
  

  Transcript Intelligence: Ascendis Pharma Q4 Earnings Guidance ($221.49, -2.70)

• 07:45 PM ET Feb 11, 2026
  

  Transcript Intelligence: Ascendis Pharma Q4 Earnings Themes ($221.49, -2.70)

• 07:45 PM ET Feb 11, 2026
  

  Transcript Intelligence: Ascendis Pharma Q4 Earnings Q&A ($221.49, -2.70)

• 04:53 PM ET Feb 09, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 04:05 PM ET Feb 11, 2026
  

  StreetAccount Metrics Recap - Ascendis Pharma Q4 Earnings ($221.49, 0.00)

• 04:04 PM ET Feb 11, 2026
  

  Ascendis Pharma reports Q4 EPS (€0.55) vs FactSet (€0.19) [16 est, (€2.23)-0.36] ($221.49, 0.00)

• 08:44 AM ET Feb 10, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 12:37 PM ET Feb 09, 2026
  

  StreetAccount Consensus Metrics Preview - Ascendis Pharma Q4 Earnings ($221.65, -0.50)